IsletNexus Research Publications
Explore our extensive research publications showcasing advancements in diabetes, stem cell therapy, and beta-cell failure mechanisms by our dedicated team.
Martinez-Morata, I., Dennehy, K., Chepurny, O., Delibasi, T., Schilling, K., Navas-Acien, A., & El Muayed, M. (2025). Type 2 diabetes mellitus and zinc dysregulation: From basic and epidemiological evidence to interventions. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 91, 127733. https://doi.org/10.1016/j.jtemb.2025.127733
Tunc, S. E., Delibasi, B. T., & Delibasi, T. (2025). Targeting Inflammation in Type 2 Diabetes: The Role of Colchicine. Current diabetes reviews, 10.2174/0115733998298686250526041742. Advance online publication. https://doi.org/10.2174/0115733998298686250526041742
Turan GA, Delibasi T. Gestational Diabetes and Infertility. Journal of Diabetes Mellitus. 2023 May;13 (2): 203-221
Lacroix A, Bronstein MD, Schopohl J, Delibasi T, Salvatori R, Li Y, Barkan A, Suzaki N, Tauchmanova L, Ortmann CE, Ravichandran S, Petersenn S, Pivonello R. Long-acting pasireotide improves clinical signs and quality of life in Cushing's disease: results from a phase III study. J Endocrinol Invest. 2020. Nov;43 (11):1613-1622
Pagidipati NJ, Zheng Y, Green JB, McGuire DK, Mentz RJ, Shah S, Aschner P, Delibasi T, Rodbard HW, Westerhout CM, Holman RR, Peterson ED; TECOS Study Group. Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS. Is Heart J. 2020 Jan; 219:47-57?
Nauck MA, McGuire DK, Pieper KS, Lokhnygina Y, Strandberg TE, Riefflin A, Delibasi T, Peterson ED, White HD, Scott R, Holman RR. Sitagliptin does not reduce the risk of cardiovascular death or hospitalization for heart failure following myocardial infarction in patients with diabetes: observations from TECOS. Cardiovasc Diabetol. 2019 Sep 3;18(1):116
Pagidipati NJ, Navar AM, Pieper KS, Green JB, Bethel MA, Armstrong PW, Josse RG, McGuire DK, Lokhnygina Y, Cornel JH, Halvorsen S, Strandberg TE, Delibasi T, Holman RR, Peterson ED; TECOS Study Group. Secondary Prevention of Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus: International Insights Fromthe TECOS Trial (Trial Evaluating Cardiovascular Outcomes with Sitagliptin). Circulation. 2017 Sep 26;136(13):1193-1203.
Senturk B, Demircan BM, Ozkan AD, Tohumeken S, Delibasi T, Guler MO, Tekinay AB. Diabetic wound regeneration using heparin-mimetic peptide amphiphile gel indb/db mice. Biomater Sci. 2017 Jun 27;5(7):1293-1303
Arslan MS, Tutal E, Sahin M, Karakose M, Ucan B, Ozturk G, Cakal E, Biyikli, Gencturk Z, Ozbek M, Delibasi T. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes. Endocrine. 2016 Oct 15.
Paz-Filho GJ, Delibasi T, Erol HK, Wong ML, Licinio J. Cellular Immunity Before and After Leptin Replacement Therapy. J Pediatr Endocrinol Metab, 22, 1069-1074 (2009)
Paz-Filho G, Delibasi T, Erol HK, Wong ML, Licino J. Congenital Leptin Deficiency and Thyroid Function. Thyroid Res, 4, 11 (2009).